within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J06B_Immunoglobulins.J06BB11_HepatitisAImmunoglobulin;

model HepatitisAImmunoglobulin
  extends Pharmacolibrary.Drugs.ATC.J.J06BB11;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J06BB11</td></tr><td>route:</td><td>intramuscular</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Hepatitis A immunoglobulin (human) is a purified antibody preparation derived from pooled human plasma containing high titers of hepatitis A antibodies. It is used for prophylaxis against hepatitis A virus infection, particularly in post-exposure cases or for travelers to endemic regions. It is approved and in use for these indications as a passive immunization product.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported in healthy adult volunteers receiving a single intramuscular injection of immunoglobulin.</p><h4>References</h4><ol><li><p>Kankam, M, et al., &amp; Vilardell, D (2020). Polyvalent Human Immune Globulin: A Prospective, Open-Label Study Assessing Anti-Hepatitis A Virus (HAV) Antibody Levels, Pharmacokinetics, and Safety in HAV-Seronegative Healthy Subjects. <i>Advances in therapy</i> 37(5) 2373–2389. DOI:<a href=\"https://doi.org/10.1007/s12325-020-01327-9\">10.1007/s12325-020-01327-9</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32301062/\">https://pubmed.ncbi.nlm.nih.gov/32301062</a></p></li><li><p>Young, MK, et al., &amp; Cripps, AW (2020). Pharmacokinetic modeling to determine the minimum effective dose of disease-specific antibodies for preventing hepatitis A post-exposure. <i>Expert opinion on drug metabolism &amp; toxicology</i> 16(7) 641–644. DOI:<a href=\"https://doi.org/10.1080/17425255.2020.1763303\">10.1080/17425255.2020.1763303</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32362179/\">https://pubmed.ncbi.nlm.nih.gov/32362179</a></p></li><li><p>Ragni, MV, et al., &amp; Krause, DS (2000). Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with haemophilia. <i>Haemophilia : the official journal of the World Federation of Hemophilia</i> 6(2) 98–103. DOI:<a href=\"https://doi.org/10.1046/j.1365-2516.2000.00386.x\">10.1046/j.1365-2516.2000.00386.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/10781196/\">https://pubmed.ncbi.nlm.nih.gov/10781196</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end HepatitisAImmunoglobulin;
